Related Experiment Video
Updated: Oct 21, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
11.0K
Negative Correlation Between Circular RNA SMARC5 and MicroRNA 432, and Their Clinical Implications in Bladder Cancer
Zhijia Zhang1, Yanxia Sang2, Zhengan Liu2
1Shanxi Provincial People's Hospital, Taiyuan, China.
Technology in Cancer Research & Treatment
|September 6, 2021
Summary
High expression of circular RNA SMARCA5 (circ-SMARCA5) and low expression of microRNA 432 (miR-432) correlate with advanced bladder cancer features and poor survival. These molecules may serve as potential prognostic markers for bladder cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bladder cancer is a significant global health concern.
- Identifying reliable prognostic markers is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the correlation of circular RNA SMARCA5 (circ-SMARCA5) and microRNA 432 (miR-432) with clinical characteristics and survival in bladder cancer patients.
Main Methods:
- Retrospective review of 156 bladder cancer patients' clinicopathologic and survival data.
- Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect circ-SMARCA5 and miR-432 expression in tumor and adjacent tissues.
Main Results:
- Circ-SMARCA5 was upregulated, while miR-432 was downregulated in bladder tumor tissues.
- High circ-SMARCA5 expression correlated with larger tumor size, advanced stage, and lymph node metastasis.
- High miR-432 expression correlated with smaller tumor size, lower stage, and less metastasis.
- High circ-SMARCA5 expression was associated with shorter disease-free survival (DFS) and overall survival (OS).
- High miR-432 expression was associated with longer DFS and OS.
- Circ-SMARCA5 was identified as an independent predictive factor for worse DFS and OS.
Conclusions:
- Elevated circ-SMARCA5 and decreased miR-432 expression are linked to aggressive tumor features and poor prognosis in bladder cancer.
- Circ-SMARCA5 and miR-432 show potential as prognostic biomarkers for bladder cancer.

